department of otolaryngology-head and neck surgery

Grants Awarded

Thank you for your interest in our research. For your convenience we've listed grants awarded by principle investigator and by title.


Terry A. Day, M.D.

Rita M. Young, M.D., PI, Terry A. Day, M.D., Co-Investigator. Targeting mTOR as a Novel Mechanism-Based Therapy for Head and Neck Cancer. NIH/NCI, $99,999, 7/2009-6/2011.

>> Return to top of page...

Christopher M. Discolo, M.D.

Christopher M. Discolo, M.D., PI, David R. White, M.D., Co-Investigator. A Prospective, Multi-Center, Non-Randomized Clinical Trial to Evaluate the Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children. OtoSonics Inc., $23,500, 7/2010-6/2011.

Christopher M. Discolo, M.D., PI. Non-Randomized, Feasibility Trial to Evaluate the Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children. OtoSonics Inc., $15,000, 4/2010-3/2011.

>> Return to top of page...

Judy Dubno, Ph.D.

Judy R. Dubno, Ph.D., PI. Auditory Analysis and Speech Recognition. NIH/NIDCD, $137,625, 7/17/09-6/30/11.

Judy R. Dubno, Ph.D., PI. Auditory Analysis and Speech Recognition. NIH/NIDCD, $297,338, 7/1/06-/6/30/11.

Judy R. Dubno, Ph.D., PI. Automated Hearing Tests. Audiology Inc. and NIH/NIDCD, $132,868, 4/1/10-3/13/13.

Judy R. Dubno, Ph.D., PI. Experimental and Clinical Studies of Presbyacusis. NIH/NIDCD, $348,432, 7/17/09-6/30/11.

Judy R. Dubno, Ph.D., PI. Experimental and Clinical Studies of Presbyacusis. NIH/NIDCD, $1,843,561, 8/1/08-7/31/13.

Judy R. Dubno, Ph.D., PI. Multi-site Study of the Efficacy of Speech Perception Training for Hearing-Aid Users. NIH/NIDCD, $300,640, 7/1/10-6/30/15.

>> Return to top of page...

Mark Eckert, Ph.D.

Mark Eckert, Ph.D., PI. Neural Changes Underlying Speech-Perception Training in the Aging Brain. Deafness Research Foundation, $50,000, 9/1/09-8/31/10.

>> Return to top of page...

M. Boyd Gillespie, M.D.

M. Boyd Gillespie, M.D., PI, Frank J. Overdyk, M.D., Co-Investigator. Added Value of Sleep Nasendoscopy - STUDY #1. Gyrus, $77,200, 1/2010-6/2011..

M. Boyd Gillespie, M.D., PI. The Evaluation of Ethicon's Surgical Techniques and Devices Treating Obstructive Sleep Apnea in Human Cadaver. Ethicon, $19,240, 11/2009-10/2010.

M. Boyd Gillespie, M.D., PI. Radioablative Surgery to Improve CPAP Compliance STUDY #3. Gyrus, $42,500, 1/2010-12/2011.

M. Boyd Gillespie, M.D., PI. Radioablative Surgery Versus CPAP in Older Adults with Mild-to-Moderate Sleep Apnea. Gyrus, $36,250, 1/2010-12/2011.

>> Return to top of page...

Kelly C. Harris, M.D.

Kelly C. Harris, M.D., PI. Auditory Temporal Processing in the Aging Ear and Brain (Clinical Research). NIH/NIDCD, $52,719, 7/17/09-6/30/10.

Kelly C. Harris, M.D., PI. Auditory Temporal Processing in the Aging Ear and Brain (Research Training). NIH/NIDCD, $124,127, 9/1/07-8/31/12.

>> Return to top of page...

Joshua D. Hornig, M.D.

Joshua D. Hornig, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. A Prospective, Blinded, Randomized, Controlled Trial Comparing Wound Drainage and Post-Operative Complications with and without the Use of EVICEL Fibrin Sealant in Thyroidectomy. Ethicon, $100,000, 3/2010-2/2012.

>> Return to top of page...

Paul R. Lambert, M.D.

Paul R. Lambert, M.D., PI, Ted A. Meyer, M.D., Co-Investigator. An Open-Label, Long-Term, Treatment Study to Assess the Long-Term, Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus. Icon Clinical Research Inc. and Merz Pharmaceuticals, $131,300, 12/2009-12/2011.

Paul R. Lambert, M.D., PI, Ted A. Meyer, M.D., Co-Investigator. An Open-Label, Long-Term, Treatment Study to Assess the Long-Term, Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus. Icon Clinical Research Inc. and Merz Pharmaceuticals, $123,500, 8/2010-8/2012.

Paul R. Lambert, M.D., PI. A Prospective, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Phase 1B Study of Oto-104 Given as a Single Intratympanic Injection in Subjects with Unilateral Meniere's Disease. Otonomy Inc., $106,563, 12/2009-12/2010.

>> Return to top of page...

Bonnie Martin-Harris, Ph.D.

Bonnie Martin-Harris, Ph.D., PI. Efficacy of Laryngeal High Speed Videoendoscopy. University of South Carolina and NIH/NIDCD, $12,000, 2006-2011.

Bonnie Martin-Harris, Ph.D., PI. Mark and Evelyn Trammell Trust, MUSC, $150,000, 2010-2013.

Bonnie Martin-Harris, Ph.D., PI. National Database for the Modified Barium Swallowing Impairment Profile (MBSImP). Bracco Diagnostics, $88,444, 2008-2010.

Bonnie Martin-Harris, Ph.D., PI. Respiratory Phase Training Effects on Swallow Impairment in Oropharyngeal Cancer. NIH/NIDCD, $221,250, 2010-2013.

Bonnie Martin-Harris, Ph.D., PI. Web-based E-learning for the Modified Barium Swallowing Impairment Profile (MBSImP). Bracco Diagnostics, $123,045, 2008-2010.

>> Return to top of page...

Ted A. Meyer, M.D., Ph.D.

Ted A. Meyer, M.D., Ph.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. The Effects of Apical Stimulation of the Cochlea Using Fine Structure Processing. Med El Coro, $43,500, 12/2009-12/2012.

Ted A. Meyer, M.D., Ph.D., PI,, Abby Connell, MEd, Co-Investigator. Electric-Acoustic Systems (EAS) Investigational Plan. MED-EL Corporation, $30,500, 8/2010-7/2012.

Ted A. Meyer, M.D., Ph.D., PI, Meredith Edgerton, AuD, Co-Investigator. Evaluation of the ClearVoice Strategy in Adults Using HiResolution Fidelity 120 Sound Processing. Advanced Bionics, $9,750, 12/2009-12/2011.

Ted A. Meyer, M.D., Ph.D., PI, Abby Connell, MEd, Co-Investigator. Market Assessment Evaluation. Cochlear Americas, $3,750, 7/2009-7/2011.

Paul R. Lambert, M.D., PI, Ted A. Meyer, M.D., Ph.D., Co-Investigator. An Open-Label, Long-Term, Treatment Study to Assess the Long-Term, Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus. Icon Clinical Research Inc. and Merz Pharmaceuticals, $131,300, 12/2009-12/2011.

Paul R. Lambert, M.D., PI, Ted A. Meyer, M.D., Ph.D., Co-Investigator. An Open-Label, Long-Term, Treatment Study to Assess the Long-Term, Safety and Tolerability and Efficacy of Neramexane in Patients with Subjective Tinnitus. Icon Clinical Research Inc. and Merz Pharmaceuticals, $123,500, 8/2010-8/2012.

>> Return to top of page...

Shaun A. Nguyen, M.D., CPI

Shaun A. Nguyen, M.D., PI. Otology Data Collection Project CHEER. Academy of Otolaryngology – Head and Neck Surgery & Duke University, 1/2010-1/2011.

Ted A. Meyer, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. The Effects of Apical Stimulation of the Cochlea Using Fine Structure Processing. Med El Coro, $43,500, 12/2009-12/2012.

Ted A. Meyer, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Evaluation of the ClearVoice Strategy in Adults Using HiResolution Fidelity 120 Sound Processing. Advanced Bionics, $9,750, 12/2009-12/2011.

Ted A. Meyer, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Market Assessment Evaluation. Cochlear Americas, $3,750, 07/2009-7/2011.

Rodney Schlosser, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Management of Allergic Rhinitis Patients with Nasal Steroids and Low Pressure Nasal Irrigation with Isotonic Saline: A Prospective Pilot Study. NellMed Pharmaceuticals Inc., $67,380, 12/2009-6/2011.

David R. White, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Natural History Study Incidence of Otorrhea Following Tympanostomy Tube Insertion in a Cohort of Children Aged 6 Months to 12 Years. Alcon Inc., $37,750, 7/2010-6/2011.

Joshua D. Hornig, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. A Prospective, Blinded, Randomized, Controlled Trial Comparing Wound Drainage and Post-Operative Complications with and without the Use of EVICEL Fibrin Sealant in Thyroidectomy. Ethicon, $100,000, 3/2010-2/2012.

>> Return to top of page...

Rodney Schlosser, M.D.

Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Andreoli S). Ciliary dysfunction in children with otitis media and tobacco exposure. MUSC University Research Committee, $2,000, 2010.

Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Andreoli S). Ciliary dysfunction in pediatric atopic disease. AAOA, $5,000, 2009-10.

Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Mulligan JK). Contribution of VD3 deficiency to immune dysfunction in children with chronic rhinosinusitis. American Society of Pediatric Otolaryngology, $20,000, 2010-2011.

Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Mulligan JK). Effects of fungal antigen exposure on epithelial cell induction of dendritic cell maturation in patients with AFRS. AAOA, $5,000, 2009-2010.

Rodney Schlosser, M.D., Mentor and co-investigator. (PI, Mulligan JK). Effects of second hand smoke on dendritic cell regulation and function in chronic rhinosinusitis. Flight Attendants Medical Research Institute,Young Clinical Scientist Award, $225,000, 2010-2013.

Rodney Schlosser, M.D., PI. Determinants of Surgical/Medical Management Outcomes in Chronic Rhinosinusitis. American Rhinological Society & Oregon Health Sciences University, 6/2009 – 6/2012.

Rodney Schlosser, M.D., Mentor and co-investigator. (PI, O’ Connell B). Immunolocalization and regulation of Th2 cells in allergic fungal rhinosinusitis. AAOA, $5,000, 2009-10.

Rodney Schlosser, M.D., PI. Impact of Intraoperative Hydrodebrider Treatment on Post-op Sinonasal Inflammation. Medtronic Inc., $109,420, 7/2010-6/2011.

Rodney Schlosser, M.D., PI, Shaun A. Nguyen, M.D., Co-Investigator. Management of Allergic Rhinitis Patients with Nasal Steroids and Low Pressure Nasal Irrigation with Isotonic Saline: A Prospective Pilot Study. NellMed Pharmaceuticals Inc., $67,380, 12/2009-6/2011.

Rodney Schlosser, M.D., Co-investigator. (PI, Atkinson, C). Nanoparticle coupled therapeutics to inhibit smoke-induced oxidative inflammation in allergic rhinitis. SC Translational Research Institute, $50,000, 2009-2010.

Rodney Schlosser, M.D., PI. Second-hand smoke exacerbates allergic rhinitis. Flight Attendant Medical Research Institute, Clinical Innovator Award, $325,500, 2008-2011.

>> Return to top of page...

David R. White, M.D.

David R. White, M.D., PI, A prospective, randomized, double-blind placebo-controlled, multicenter, phase 1 study of OTO-201 given as a single intratympanic injection for Intra-Operative Treatment of Middle Ear Effusion in Pediatric Subjects Requiring tympanostomy tube Placement. Otonomy, Inc., $150,591.  Sept 1, 2012-present.

David R. White, M.D., PI. Surgical reduction of the inferior turbinate using a coblation device for treatment of nasal obstruction in a pediatric population. Arthrocare, $10,000.  Feb 1, 2011-August 1, 2012

Christopher M. Discolo, M.D., PI, David R. White, M.D., Co-Investigator. A Prospective, Multi-Center, Non-Randomized Clinical Trial to Evaluate the Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children. OtoSonics Inc., $23,500, 7/2010-6/2011.

David R. White, M.D., PI. Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes. Alcon Inc., $76,750, 7/2010-6/2012.

David R. White, M.D., PI. Natural History Study of Incidence of Otorrhea Following Tympanostomy Tube Insertion in a Cohort of Children Aged 6 Months to 12 Years. Alcon Laboratories, Inc., $35,250 Funding period: May 1, 2010-March 31, 2012. (1% time)

David R. White, M.D., PI. Safety and Efficacy Evaluation of Topical Moxidex Otic Solution in the Treatment of Acute Otitis Media with Otorrhea in Tympanostomy Tubes. Alcon Laboratories, Inc., $73,750, May 1, 2010-March 31, 2012.    

David R. White, M.D., PI. Gastroesophageal reflux in otitis media. National Organization for Hearing Research, $10,000, July 2000-June, 2001. 

David R. White, M.D. As Co-Investigator ;Standardization of video fluoroscopic swallow studies for bottle-fed children.  NIH/NIDCD, $396,606, July 2011-June 2014.  PI: Bonnie Martin-Harris, PhD.

David R. White, M.D. As Co-Investigator  A clinical study of the acclarent tympanostomy tube delivery system in-office. Acclarent, Inc., $3,125, August 2011-October 2012.  PI: Christopher M. Discolo, MD.

David R. White, M.D. As Co-Investigato.r Smoke exposure and oxidative inflammation in pediatric chronic rhinosinusitis. American Society of Pediatric Otolaryngology Core Grant., $10,000. July 1, 2010-June 30, 2011.  PI: Jennifer Mulligan, PhD.

David R. White, M.D. As Co-Investigator. Ciliary dysfunction in children with otitis media and tobacco exposure. University Research Committee Research Award, Medical University of South Carolina, $2,000, June 1-October 31, 2010.  PI: Steven Andreoli, MD.

David R. White, M.D. As Co-Investigator. Ciliary dysfunction in pediatric atopic disease. American Academy of Otolaryngic Allergy Foundation, $5,000, July 2009- June 2010.   PI: Steven M. Andreoli, MD

David R. White, M.D. As Co-Investigator. A Prospective, Multi Center, Non-Randomized Clinical Trial To Evaluate The Ear Effusion Detection and Characterization System (EEDCS) to Detect and Characterize Middle Ear Fluid in Children. Sponsored by Otosonics Medical, $25,000, July 2009-July 2012.  PI:Christopher M. Discolo, MD.

David R. White, M.D. As Co-Investigator. Non-randomized feasibility trial to evaluate the ear effusion detection and characterization system (EEDCS) to detect middle ear fluid in children. Sponsored by Otosonics Medical, $15,000, July 2009-present. PI:Christopher M. Discolo, MD.

>> Return to top of page...

Rita M. Young, Ph.D.

Rita M. Young, Ph.D., PI. Defining and Interrupting the Pathways that Lead to HNSCC Invasiveness. VA Medical Center, $125,000, 10/1/07-9/30/11.

Rita M. Young, Ph.D., PI. Vitamin D Plus Celecoxib Therapy to Stimulate Intratumoral Immune Reactivity. VA Medical Center, $159,000, 10/1/09-9/30/14.

Rita M. Young, Ph.D., PI. Macrophage-Driven Progression of Premalignant Oral Lesions Toward Invasiveness. NIH/NIDCR, $315,000, 8/1/08-6/30/12.

Rita M. Young, Ph.D., PI. Immunotherapy to Prevent Oral Permalignant Lesion Recurrence and Oral Cancer. NIH/NCI, $261,450, 1/1/09-12/31/13.

>> Return to top of page...